Compositions of obeticholic acid and methods of use
US-2026000682-A1 · Jan 1, 2026 · US
This page is not indexed by search engines while we improve data quality.
Pruzanski Mark patents
Pruzanski Mark is listed as an inventor on 33 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Pruzanski Mark |
| Total patents | 33 |
| First publication | Jul 28, 2015 |
| Latest publication | Jan 1, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Pharmaceutical compositions for combination therapy
US-2025367217-A1 · Dec 4, 2025 · US
Pharmaceutical compositions for combination therapy
US-2025367216-A1 · Dec 4, 2025 · US
Pharmaceutical compositions for combination therapy
US-12337003-B2 · Jun 24, 2025 · US
Pharmaceutical compositions for combination therapy
US-2022280533-A1 · Sep 8, 2022 · US
Pharmaceutical compositions for combination therapy
US-2022280534-A1 · Sep 8, 2022 · US
Compositions of obeticholic acid and methods of use
US-2022133745-A1 · May 5, 2022 · US
Pharmaceutical compositions for combination therapy
US-11311557-B2 · Apr 26, 2022 · US
Treatment of fibrosis using fxr ligands
US-2021346400-A1 · Nov 11, 2021 · US
Treatment of fibrosis using FXR ligands
US-10987362-B2 · Apr 27, 2021 · US
Recent patents
Latest publications not already listed above.
FXR agonist compositions for combination therapy
US-10894054-B2 · Jan 19, 2021 · US
Treatment of fibrosis using fxr ligands
US-2020397803-A9 · Dec 24, 2020 · US
Compositions of obeticholic acid and methods of use
US-10758549-B2 · Sep 1, 2020 · US
Compositions of obeticholic acid and methods of use
US-10751349-B2 · Aug 25, 2020 · US
Compositions of obeticholic acid and methods of use
US-2020171053-A1 · Jun 4, 2020 · US
Compositions of obeticholic acid and methods of use
US-10646499-B2 · May 12, 2020 · US
Compositions of obeticholic acid and methods of use
US-2020054650-A1 · Feb 20, 2020 · US
Compositions of obeticholic acid and methods of use
US-2020046736-A1 · Feb 13, 2020 · US
Compositions of obeticholic acid and methods of use
US-2020046735-A1 · Feb 13, 2020 · US
Compositions of obeticholic acid and methods of use
US-2019255071-A1 · Aug 22, 2019 · US
Treatment of fibrosis using FXR ligands
US-10258633-B2 · Apr 16, 2019 · US
Compositions of obeticholic acid and methods of use
US-2019076446-A1 · Mar 14, 2019 · US
Compositions of obeticholic acid and methods of use
US-10052337-B2 · Aug 21, 2018 · US
Pharmaceutical compositions for combination therapy
US-2018117065-A1 · May 3, 2018 · US
Treatment of Pulmonary Disease
US-2018064729-A1 · Mar 8, 2018 · US
Pharmaceutical compositions for combination therapy
US-2018008616-A1 · Jan 11, 2018 · US
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
US-9763964-B2 · Sep 19, 2017 · US
Treatment of fibrosis using fxr ligands
US-2017165277-A1 · Jun 15, 2017 · US
Compositions of obeticholic acid and methods of use
US-2017035784-A1 · Feb 9, 2017 · US
Treatment of fibrosis using FXR ligands
US-9498484-B2 · Nov 22, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Intercept Pharmaceuticals Inc | 33 |
| Sumitomo Dainippon Pharma Co Ltd | 11 |
| Fiorucci Stefano | 2 |
| Pellicciari Roberto | 2 |
| Pruzanski Mark | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/575 | 33 |
| A61P1/16 | 31 |
| A61P43/00 | 28 |
| A61P31/14 | 23 |
| A61K45/06 | 22 |